State of Wisconsin Investment Board’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-79,065
| Closed | -$429K | – | 2325 |
|
|
2024
Q4 | $429K | Buy |
+79,065
| New | +$483K | ﹤0.01% | 1874 |
|
|
2024
Q3 | – | Sell |
-37,015
| Closed | -$402K | – | 2353 |
|
|
2024
Q2 | $402K | Sell |
37,015
-2,204
| -6% | -$28.2K | ﹤0.01% | 1925 |
|
|
2024
Q1 | $735K | Sell |
39,219
-6,970
| -15% | -$161K | ﹤0.01% | 1544 |
|
|
2023
Q4 | $1M | Buy |
46,189
+1,253
| +3% | +$24.8K | ﹤0.01% | 1396 |
|
|
2023
Q3 | $925K | Sell |
44,936
-4,450
| -9% | -$129K | ﹤0.01% | 1421 |
|
|
2023
Q2 | $2.32M | Sell |
49,386
-2
| -0% | -$100 | 0.01% | 1257 |
|
|
2023
Q1 | $2.07M | Sell |
49,388
-4,281
| -8% | -$184K | 0.01% | 1294 |
|
|
2022
Q4 | $2.05M | Sell |
53,669
-139
| -0.3% | -$5.31K | 0.01% | 1316 |
|
|
2022
Q3 | $2.11M | Sell |
53,808
-3,605
| -6% | -$139K | 0.01% | 1327 |
|
|
2022
Q2 | $1.85M | Buy |
57,413
+9,738
| +20% | +$326K | ﹤0.01% | 1386 |
|
|
2022
Q1 | $1.58M | Buy |
47,675
+41,428
| +663% | +$1.56M | ﹤0.01% | 1552 |
|
|
2021
Q4 | $266K | Sell |
6,247
-193
| -3% | -$8.08K | ﹤0.01% | 2034 |
|
|
2021
Q3 | $285K | Buy |
6,440
+304
| +5% | +$13.9K | ﹤0.01% | 1975 |
|
|
2021
Q2 | $349K | Sell |
6,136
-354
| -5% | -$25K | ﹤0.01% | 1838 |
|
|
2021
Q1 | $486K | Sell |
6,490
-94
| -1% | -$7.71K | ﹤0.01% | 1610 |
|
|
2020
Q4 | $570K | Sell |
6,584
-270
| -4% | -$19.9K | ﹤0.01% | 1489 |
|
|
2020
Q3 | $419K | Buy |
6,854
+60
| +0.9% | +$3.04K | ﹤0.01% | 1541 |
|
|
2020
Q2 | $282K | Sell |
6,794
-240
| -3% | -$8.71K | ﹤0.01% | 1569 |
|
|
2020
Q1 | $202K | Sell |
7,034
-24,072
| -77% | -$1.39M | ﹤0.01% | 1568 |
|
|
2019
Q4 | $2.25M | Buy |
31,106
+23,962
| +335% | +$2.95M | 0.01% | 1119 |
|
|
2019
Q3 | $1M | Sell |
7,144
-54
| -0.8% | -$9.03K | ﹤0.01% | 1143 |
|
|
2019
Q2 | $1.32M | Sell |
7,198
-1,917
| -21% | -$327K | ﹤0.01% | 1078 |
|
|
2019
Q1 | $1.45M | Buy |
9,115
+400
| +5% | +$57.9K | ﹤0.01% | 1065 |
|
|
2018
Q4 | $835K | Hold |
8,715
| – | – | ﹤0.01% | 1176 |
|
|
2018
Q3 | $1.23M | Sell |
8,715
-193
| -2% | -$29.8K | ﹤0.01% | 1143 |
|
|
2018
Q2 | $1.39M | Sell |
8,908
-34,092
| -79% | -$5.35M | ﹤0.01% | 1069 |
|
|
2018
Q1 | $6.93M | Buy |
43,000
+5,000
| +13% | +$849K | 0.02% | 772 |
|
|
2017
Q4 | $6.26M | Buy |
38,000
+4,666
| +14% | +$452K | 0.02% | 804 |
|
|
2017
Q3 | $2.08M | Buy |
33,334
+8,334
| +33% | +$655K | 0.01% | 961 |
|
|
2017
Q2 | $1.99M | Buy |
+25,000
| New | +$1.81M | 0.01% | 950 |
|
Other funds holding SAGE
MAP
CP
TAL
DTC
BFM
State of Wisconsin Investment Board's SAGE Position: Q1 2025 in Review
State of Wisconsin Investment Board sold out of Sage Therapeutics (SAGE) in Q1 2025, closing a stake of 79,065 shares — an estimated $429K sold.
State of Wisconsin Investment Board first reported a position in SAGE in Q2 2017 and held it in 30 quarters. The position peaked at $6.93M in Q1 2018. 198 funds tracked by Wall St. Rank hold SAGE as of Q1 2025.
- State of Wisconsin Investment Board reported no remaining Sage Therapeutics position as of Q1 2025 after selling out during the quarter.
- State of Wisconsin Investment Board sold 79,065 Sage Therapeutics shares in Q1 2025, an estimated $429K.
- State of Wisconsin Investment Board first reported a position in Sage Therapeutics in Q2 2017 and held it in 30 quarters.
- State of Wisconsin Investment Board's Sage Therapeutics position peaked at $6.93M in Q1 2018.
- 198 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2025.
Based on State of Wisconsin Investment Board's 13F filing for Q1 2025, filed 15 May 2025.